BIOSPAIN 2026 | HEALTH & LIFE SCIENCES REPORT

High standards, difficult access: Europe's healthcare innovation challenge

 

Europe is making progress in healthcare innovation, but bringing promising technologies to market remains a major challenge.

What happens after innovation is developed and funded?

Explore the key insights from our closed-door discussion at BIOSPAIN 2026, where healthcare and life sciences experts examined the barriers between innovation, market access and real-world adoption.

Cover - Report BIOSPAIN

From innovation to real-world adoption

 

Based on our closed-door discussion at BIOSPAIN 2026, the report explores the challenges facing Europe's healthcare innovators beyond technology development and funding.

Beyond funding

Why access to capital is only part of the challenge, and what makes the transition from development to commercialisation so difficult.

Regulation & market access

How certification, regulatory requirements and fragmented healthcare systems affect the path to market.

From fundable to adoptable

Why strong technology and successful funding do not automatically translate into healthcare adoption.

The path forward

Explore the role of early collaboration, clearer regulatory pathways and first-adoption opportunities in bringing healthcare innovation to market.

Funding innovation is only part of the journey

 

Europe has strengthened its ability to support healthcare innovation. Yet the journey from promising technology to successful adoption involves challenges that extend far beyond securing funding.

FROM

Fundable

Strong science, innovation potential and alignment with public funding priorities.

TO

Adoptable

Healthcare solutions with a viable route to market, clear clinical value and the potential to reach patients and healthcare systems.

What needs to change to bridge the gap?

Working on healthcare innovation? Let's talk

 

Whether you are developing a new healthcare technology, exploring European funding opportunities or navigating the challenges of bringing innovation to market, our team can help you assess the next steps.

Lara Valentín

Lara Valentín

Team Leader Circular Bioeconomy

Talk with Lara
Francesco Sottile

Francesco Sottile

Senior Innovation Consultant

Talk with Francesco

What does it take to make healthcare innovation adoptable?

Explore the key insights from our BIOSPAIN 2026 discussion and discover the challenges and opportunities shaping the journey from healthcare innovation to real-world adoption.